Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessTuberculosis

Whole genome sequencing of drug-resistant Mycobacterium tuberculosis isolates in Victoria, Australia

International Journal of Infectious Diseases·

Thinley Dorji, Kristy Horan, Norelle L. Sherry, Ee Laine Tay, Maria Globan, Linda Viberg, Katherine Bond, Justin T. Denholm, Benjamin P. Howden, Patiyan Andersson

DOI
10.1016/j.ijid.2023.11.010
PMID
37967715
PMCID
OpenAlex
W4388666041
Study type
Cohort study
Publisher
Elsevier BV
Article type
journal-article
Integrity
current

Why this research matters now

The findings support the value of whole genome sequencing for identifying clusters and resistance mutations in low-burden settings, which can inform contact tracing, surveillance, and treatment strategies for drug-resistant TB.

01

Structured evidence summary

Research question

The study investigated drug-resistant Mycobacterium tuberculosis isolates in Victoria, Australia using whole genome sequencing to identify resistance-conferring mutations, lineages, clusters, and how local sequences compared with international context.

Study design

Retrospective cohort study using whole genome sequencing of 155 drug-resistant TB isolates collected between 2018-2021 in Victoria, Australia, with bioinformatic analysis for resistance mutations, lineages, and phylogenetic relationships.

Population and setting

Victoria, Australia, 2018-2021: 155 genomically defined drug-resistant TB isolates from a low-burden setting, predominantly affecting migrant populations.

Main findings

Isoniazid-resistant TB was the most common form (65.8%) of drug-resistant TB; 42% of isolates were lineage 2 and 35% lineage 1. Common resistance mutations were identified in katG (Ser315Thr) and fabG1 (-15 C>T) genes, with rpoB Ser450Leu most frequent. Phylogenetic analysis indicated importation events were the primary source with little evidence of local transmission (five isolate pairs).

Public-health relevance

The findings support the value of whole genome sequencing for identifying clusters and resistance mutations in low-burden settings, which can inform contact tracing, surveillance, and treatment strategies for drug-resistant TB.

Important limitations

This summary is limited to the supplied single-article abstract/metadata and requires access to the original full paper for decision-grade interpretation. The retrospective cohort design and single-region focus may limit generalizability.

GIDS interpretation

This study provides genomic context for drug-resistant TB in Victoria, Australia, demonstrating that importation, rather than local transmission, appears to drive drug-resistant TB in this setting. The findings offer baseline genomic epidemiology data relevant to surveillance systems.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 12 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topicaddresses topicaddresses topicaddresses topicaddresses topicaddresses topicevaluates interventionhas pathogen typestudied instudied population settinguses study design